[Addendum to Commission A13-37

[Addendum to Commission A13-37 (regorafenib)]

Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen

Record ID 32018002983

German

Original Title: Addendum zum Auftrag A13-37 (Regorafenib)

Details

Project Status: Completed

URL for project: https://www.iqwig.de/projekte/a14-09.html

Year Published: 2014

URL for published report: https://www.iqwig.de/download/A14-09_Addendum-zum-Auftrag-A13-37_Regorafenib.pdf

English language abstract: There is no English language summary available

Publication Type: Full HTA

Country: Germany

MeSH Terms

Colorectal Neoplasms
Phenylurea Compounds
Pyridines
Antineoplastic Agents

Keywords

Regorafenib
Colorectal Neoplasms
Benefit Assessment

Contact

Organisation Name: Institute for Quality and Efficiency in Health Care (IQWiG)

Contact Address: IQWiG, Siegburger Str. 237, 50679 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851

Contact Email: berichte@iqwig.de

Copyright: Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)

This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.